Introduction {#j_jvetres-2019-0022_s_001}
============

Bovine respiratory disease complex (BRDC) is a major problem for cattle breeders worldwide, causing serious economic losses. BRDC is associated with infection by certain viruses, bacteria, and parasites ([@j_jvetres-2019-0022_ref_033]). In addition to these infectious agents, stress factors such as transport, gestation, and poor management conditions play an important role in the onset of the disease ([@j_jvetres-2019-0022_ref_030]). Bovine herpes virus 1 (BHV-1), bovine respiratory syncytial virus (BRSV), and bovine parainfluenza virus-3 (BPIV3) are the most common viral agents of the respiratory system. Some opportunistic agents (*Mannheimia haemolytica, Pasteurella multocida, Haemophilus somnus*, and *Mycoplasma* spp.) contribute to the appearance of clinical signs and thus increase mortality and cause losses in the herds ([@j_jvetres-2019-0022_ref_018]). Suppressed immunity also has an important role in the prognosis. Diseases such as bovine leucosis and bovine viral diarrhoea suppress immunity and lead to more animal loss by worsening clinical symptoms.

BPIV3 (the new name of which is bovine respirovirus 3) is an RNA virus assigned to the *Paramyxoviridae* family under the *Respirovirus* genus. BRSV (the new name of which is bovine orthopneumovirus) is in the *Pneumoviridae* family under the *Orthopneumovirus* genus. To date, three genotypes of BPIV3 have been described. These genotypes, termed A, B, and C, were differentiated based on phylogenetic analysis. Genotype A strains have been isolated in North America, China, and Japan. Genotype B was originally found in Australia. Isolations of genotype C were in China, South Korea, and Japan. In addition, all three genotypes have been reported in Argentina ([@j_jvetres-2019-0022_ref_023]).

Initially BRSV subgroups were identified (A, B, and AB or intermediary) based on monoclonal antibody and polyclonal sera analyses against F and G proteins ([@j_jvetres-2019-0022_ref_031]). Additionally, Valarcher *et al*. ([@j_jvetres-2019-0022_ref_036]) proposed that six genetic subgroups may be found in BRSV strains, when F, G, and nucleoprotein sequences are phylogenetically analysed by maximum-likelihood algorithms. Therefore, six subgroups were detected in BRSV. These subgroups termed I (the subgroup B prior to the recommendation of Valarcher *et al*. ([@j_jvetres-2019-0022_ref_036])), III (subgroup A), and II, IV, V, and VI (subgroup AB) were differentiated based on phylogenetic analysis. Subgroup I consists of European strains (UK and Switzerland). Subgroup III includes viruses exclusively from the USA. Subgroup II aggregates strains from the Netherlands, Belgium, France, Denmark, Sweden, and Japan. Subgroup IV is of European and USA strains while subgroups V and VI are found only in French and Belgian isolates ([@j_jvetres-2019-0022_ref_029], [@j_jvetres-2019-0022_ref_036]). Subgroup VII was detected in later years ([@j_jvetres-2019-0022_ref_009]) and some strains are known which are still not classified (these are regarded as untyped) ([@j_jvetres-2019-0022_ref_010]).

BPIV3 and BRSV can cause mild symptoms or subclinical disease when present alone. However, when there is a co-infection, they may cause bronchopneumonia, severe cough, high fever, and nasal discharge and contribute to a more serious clinical course of infection ([@j_jvetres-2019-0022_ref_033]). Regardless of the infecting agent in BRDC, clinical symptoms may be similar and the process of detecting the underlying primal agent may be hindered due to mixed bacterial infections. This situation makes viral diagnosis difficult and decreases the specificity and sensitivity of the molecular methods (when compared to immunofluorescence antibody tests) ([@j_jvetres-2019-0022_ref_015]).

Data on virological detection of these agents in Turkey is limited ([@j_jvetres-2019-0022_ref_002], [@j_jvetres-2019-0022_ref_006]), but there are more studies on seroprevalence of these viruses among cattle herds. The studies reported lowest and highest seropositivity of 11% ([@j_jvetres-2019-0022_ref_001]) and 92.8% ([@j_jvetres-2019-0022_ref_013]) for BPIV3 and 28% ([@j_jvetres-2019-0022_ref_001]) and 94% ([@j_jvetres-2019-0022_ref_013]) for BRSV. Serological studies on BRSV and BPIV3 were previously conducted in different geographic regions of our country. In these studies the following percentage values for BRSV and BPIV3 prevalence were determined respectively: Alpay *et al*. ([@j_jvetres-2019-0022_ref_005]) 26.6% and 44.6%, Alkan *et al*. ([@j_jvetres-2019-0022_ref_003]) 62.0% and 44.6%, Avci *et al*. ([@j_jvetres-2019-0022_ref_007]) 78.2% and 85.6%, Çabalar and Can Sahna ([@j_jvetres-2019-0022_ref_011]) 67.3% and 18%, Yavru *et al*. ([@j_jvetres-2019-0022_ref_040]) 46% and 53.9%, and Yesilbag and Gungor ([@j_jvetres-2019-0022_ref_041]) 73.0% and 43%. These studies were conducted either countrywide ([@j_jvetres-2019-0022_ref_003]) or in selected regions ([@j_jvetres-2019-0022_ref_040], [@j_jvetres-2019-0022_ref_041]).

The aim of this study was the detection and molecular characterisation of BPIV3 and BRSV strains retrieved from nasal swabs and lung samples of cows in the eastern region of Turkey. The determination of BRSV and BPIV3 types and associated co-infections for respiratory system infections was conducted.

Material and Methods {#j_jvetres-2019-0022_s_002}
====================

**Sampling**. Nasal swabs and lung tissue samples were gathered from cattle from the Erzurum district and its neighbouring provinces. [Table 1](#j_jvetres-2019-0022_tab_001){ref-type="table"} shows the origin and quantity of the collected samples. A total of 155 animals were used in the study (92 males and 63 females). The herd consisted of cross-breeds of brown Swiss, Holstein, and Simmental. The age of the animals ranged between 9 months and 5 years and their mean age was 1.4 years. The males were in the fattening period and kept in open sheds; the lactating females were housed in free stall barns. Samples were acquired from animals with nasal discharge and severe coughing. In total 155 samples were collected including 28 lung tissue samples and 127 nasal swabs. Although sampling was performed throughout the year, the winter and autumn months were generally preferred as the sampling period ([Table 1](#j_jvetres-2019-0022_tab_001){ref-type="table"}).

###### 

Sampling locations, number of samples, and type of material

  No      Sampling region                                    Number of samples   Material
  ------- -------------------------------------------------- ------------------- ------------
  1       Erzurum slaughterhouse (1^st^ period, Dec 2013)    8                   Lung
  2       Erzurum slaughterhouse (2^nd^ period, Apr 2014)    10                  Lung
  3       Erzurum slaughterhouse (3^rd^ period, Sept 2014)   7                   Lung
  4       Erzurum slaughterhouse (4^th^ period, Jan 2015)    3                   Lung
  5       Erzurum Centre (1^st^ period, Mar 2014)            7                   Nasal swab
  6       Erzurum Centre (2^nd^ period, Dec 2014)            5                   Nasal swab
  7       Erzurum--Aziziye Province                          23                  Nasal swab
  8       Erzurum--Aşkale Province                           22                  Nasal swab
  9       Erzurum--Hasankale Province                        12                  Nasal swab
  10      Erzurum--Horasan Province                          15                  Nasal swab
  11      Erzurum--Oltu Province                             5                   Nasal swab
  12      Erzurum--Tekman Province                           2                   Nasal swab
  13      Erzurum--Şenkaya Province                          1                   Nasal swab
  14      Bayburt Centre                                     10                  Nasal swab
  15      Tokat Centre                                       10                  Nasal swab
  16      Gümüşhane Centre                                   15                  Nasal swab
  Total                                                      155                 

Molecular analysis {#j_jvetres-2019-0022_s_003}
==================

**Extraction of the viral nucleic acid**. Nasal swabs were vortexed in 1 mL of PBS and centrifuged at 3,000 rpm for 5 min. Supernatant was collected and 200 μL was used for extraction. A total of 25 mg of each tissue sample was homogenised in 500 μL PBS using a Tissue Lyser II homogenizer (Qiagen, Germany) and centrifuged at 3,000 rpm at room temperature, and then 200 μL of the supernatant was used for extraction. A GF-1 viral nucleic acid kit (Vivantis, Malaysia) was used for nucleic acid extraction according to the manufacturer's recommendations. All extracts were kept at −20°C before testing.

**Reverse transcription (RT)**. Viral RNA was subjected to reverse transcription using a First Strand cDNA synthesis kit (Thermo Fisher Scientific, Germany) according to the manufacturer's instructions.

**PCR**. Samples were tested by PCR using gene-specific primer pairs. Primers specific for the gene-encoding fusion region for BRSV and matrix gene for BPIV3 were used. Primer sequences, their related gene regions, and the size of estimated amplicons are shown in [Table 2](#j_jvetres-2019-0022_tab_002){ref-type="table"}. Taq DNA polymerase (Thermo Fisher Scientific, Germany) was used for the PCR which was run under previously described conditions ([@j_jvetres-2019-0022_ref_022], [@j_jvetres-2019-0022_ref_037]).

###### 

Primers used in the study

  Virus/Gene     Primers                      Primer sequences (5'-3')   Product size (bp)   References
  -------------- ---------------------------- -------------------------- ------------------- ------------
  BPIV3/Matrix   M1                           AGTGATCTAGATGATGATCCA      328                 \(22\)
  M2             GTT ATT GAT CCA ATT GCT GT                                                  
  BRSV/Fusion    B1                           AATCAACATGCAGTGCAGTTAG     710 (1^st^ round)   
  B2A            TTTGGTCATTCGTTATAGGCAT                                  \(37\)              
  B3             GTGCAGTTAGTAGAGGTTATCTTAGT                                                  
  B4A            TAGTTCTTTAGATCAAGTACTTTGCT   481 (2^nd^ round)                              

**Sequencing**. After PCR, the samples with the clearest virus-specific PCR bands were subjected to sequencing. Samples were sequenced (with the Sanger sequencing method, bi-directionally with forward and reverse primers) by the Pendik Veterinary Control Institute, Istanbul, Turkey. Obtained sequences were submitted to GenBank as bovine respirovirus 3 isolate BPIV3/TR/Erz/2014 under accession number KY511410 and bovine orthopneumovirus isolate BRSV/TR/Erz/2014 under accession number KY499619, and then were analysed phylogenetically.

**Phylogenetic analysis**. The raw sequence data and reference virus sequences obtained from GenBank were aligned using Bioedit version 7.0.5.3 software ([@j_jvetres-2019-0022_ref_017]). The aligned data were subjected to phylogenetic analysis using MEGA version 6 ([@j_jvetres-2019-0022_ref_032]) to give bootstrap analyses (1,000 replicates) by the neighbour-joining method. Tamura's two-parameter model was used and bootstrap values are shown in the phylogenetic tree.

Results {#j_jvetres-2019-0022_s_004}
=======

**Polymerase chain reaction (PCR)**. Among 155 samples, two were BRSV- and three BPIV3-positive. Four of the positive samples were swabs, and one was a lung sample. The BPIV3-positive samples originated from Erzurum-Aşkale Province (swab), Erzurum-Aziziye Province (swab), and Erzurum slaughterhouse (2^nd^ period, Apr. 2014) (lung sample). BRSV-positive samples originated from Erzurum-Aziziye Province (swab) and Bayburt-Centre (swab). All animals identified as positive were young cattle.

**Phylogenetic analysis**. Nucleotide sequences of the viruses identified in the study were closely related to Asian and European strains ([Figs 1](#j_jvetres-2019-0022_fig_001){ref-type="fig"} and [2](#j_jvetres-2019-0022_fig_002){ref-type="fig"}). The phylogenetic analysis of the fusion (F) protein of BRSV showed that the identified BRSV strain belonged to subgroup III (subgroup A) and was in the same cluster as reference viruses (KU159366 strain USII/S1/USA and FJ543092 strain 375/Brazil). The matrix gene sequence of the BPIV3 strain sequenced from a BPIV3-positive sample was classified into a cluster of genotype C.

![Phylogenetic tree generated based on the nucleotide sequence alignment of the BPIV3 matrix (M) gene region of the virus obtained in the study and viral strains from GenBank](jvetres-63-167-g001){#j_jvetres-2019-0022_fig_001}

![Phylogenetic tree generated on the basis of the nucleotide sequence alignment of the BRSV fusion (F) gene region of virus strain obtained in the study and viral strains from GenBank including human respiratory syncytial virus (HRSV)](jvetres-63-167-g002){#j_jvetres-2019-0022_fig_002}

Discussion {#j_jvetres-2019-0022_s_005}
==========

There are various diseases affecting young and old cattle worldwide. These diseases can impair the respiratory, digestive, and genital systems ([@j_jvetres-2019-0022_ref_004], [@j_jvetres-2019-0022_ref_025], [@j_jvetres-2019-0022_ref_034], [@j_jvetres-2019-0022_ref_035]). However, it is viral diseases associated with the respiratory system of cattle which are regarded as one of the main problems in cattle breeding, affecting both adults and young animals. This holds especially true when mortality rates increase in case of mixed infections. In this study, BRSV and BPIV3 virus strains were detected in pool of 155 lung tissue and nasal swab samples collected from cattle from Erzurum and neighbouring provinces.

BPIV3 and BRSV were detected by other researchers with serological and virological methods in cases of lower respiratory tract infections in cattle in Turkey ([@j_jvetres-2019-0022_ref_002], [@j_jvetres-2019-0022_ref_006], [@j_jvetres-2019-0022_ref_041]). However, these studies were not performed by molecular methods and did not include genetic characterisation as we have done. Although it was proved that in cases of lower respiratory tract infections lungs could contain a high number of virus particles ([@j_jvetres-2019-0022_ref_008]), we could detect only BPIV3, even though samples were collected in late winter. This may be because the animals were in a convalescent phase of infection or a majority of tissue samples suspected of being from pneumonic animals did not contain virus particles.

Enveloped viruses, paramyxoviruses in particular, are generally susceptible when exposed to the outside environment. Pirtle and Beran ([@j_jvetres-2019-0022_ref_027]) reported that when diluted to 10^5.5^ CCID50/mL and used to contaminate different kinds of media, the viability time was 1.5 h on rubber gloves, 20 min on skin, and a maximum of 6 h on an indoor surface. This is why samples must be admitted to the laboratory in a short time and tested in the shortest time possible. When low positivity rates are considered, both in this study and worldwide, there is always the possibility of false negativity because of virus sensitivity. PCRs specific for the gene-encoding fusion region for BRSV and the matrix gene for BPIV3 were used. The fusion gene of BRSV is a region that determines antigenic variations ([@j_jvetres-2019-0022_ref_026]), and the matrix gene for BPIV3 is responsible for viral assembly, pathogenesis, and antigenicity of strains ([@j_jvetres-2019-0022_ref_020], [@j_jvetres-2019-0022_ref_021]). Phylogenetic analysis of BRSV based on the F protein sequence classified the isolates into seven different subgroups. The topology of the phylogeny was retained when an analysis of the N and G protein gene sequences was conducted ([@j_jvetres-2019-0022_ref_036]). In our study, the determined strain was found to belong to subgroup III. Knowing the genotypes helps to determine the type-specific vaccine selection in the geographic region. Valarcher *et al*. ([@j_jvetres-2019-0022_ref_036]) identified vaccine failure among animals infected with BRSV groups V and VI, indicating that commercial vaccines act poorly against infections caused by such viral groups. Therefore, selection of vaccines is important and should be specific to the type of strains present in the region. For example in the 2000s in Europe, vaccines including Rispoval RS (strain RB-94, subgroup II), Bayovac (strain Lehmkuhl 375, subgroup III), and Vacores (strain 220/69, subgroup II) were used. If these vaccines were currently in use, Bayovac could be suitable for our country. However, *in vivo* trials would be required for other vaccines. Therefore, genotyping studies of viruses are necessary for molecular epidemiology and vaccine studies.

It is well established that respiratory tract infections are mostly mixed. These types of infections may contain viruses, bacteria, and other agents or may be caused by virus-virus or bacteria-bacteria interaction ([@j_jvetres-2019-0022_ref_018], [@j_jvetres-2019-0022_ref_033]). We investigated the samples with single or mixed (BRSV + BPIV3) infections and no other mixed infections were detected. Therefore, when viruses are the sole cause of infection, it is highly likely that they will cause subclinical infections; this may explain the low rate of detection in this study.

Aetiology in respiratory infection is quite important ([@j_jvetres-2019-0022_ref_014], [@j_jvetres-2019-0022_ref_038]). A fast and reliable method must be selected to identify the underlying agent. Genotyping studies may provide information about strains that cause serious clinical onsets related to vaccine strains and preventive status. Phylogenetic analysis of the BRSV strain was performed ([Fig. 2](#j_jvetres-2019-0022_fig_002){ref-type="fig"}). Analysis of the partial sequence of BRSV shows that our strains were more closely related to American and Brazilian (USA: KU159366; and Brazil: FJ543092) strains instead of European ones. Although the strains identified in the study are expected to be close to the European strains (because of the geographical location of Turkey), the increase in meat and live animal imports into our country over the last 5 years may be a factor in this situation, because our country imports meat from USA, Canada, Brazil, and Uruguay. Many infectious diseases may be spread among cities, countries, and continents as a result of animal or animal product transportation ([@j_jvetres-2019-0022_ref_012], [@j_jvetres-2019-0022_ref_016]). In our study, BRSV sequences showed high genetic similarity with the American and Brazilian strains. This genetic similarity among BRSV strains suggests that it could have come from Brazil or America, as a result of live animal exports.

Infection with BPIV3 is common in cattle worldwide. The virus is divided into three genotypes: A, B, and C ([@j_jvetres-2019-0022_ref_019], [@j_jvetres-2019-0022_ref_024], [@j_jvetres-2019-0022_ref_039], [@j_jvetres-2019-0022_ref_042]). Genotype A is most common in America, genotype B in Australia and genotype C is seen mostly in Asia ([@j_jvetres-2019-0022_ref_024], [@j_jvetres-2019-0022_ref_028], [@j_jvetres-2019-0022_ref_042]) ([Fig. 1](#j_jvetres-2019-0022_fig_001){ref-type="fig"}). Our samples clustered in genotype C in the phylogenetic tree. This is the first study to report BPIV3 of this type (genotype C) in Turkey. This also may be regarded as the first report in Europe since no published data is available as far as we are aware.

In conclusion, this paper is the first report of BRSV and BPIV3 infections in cattle in the east Anatolian region of Turkey and specifically Erzurum and its neighbouring provinces by molecular methods. There is a need for additional epidemiological studies to better understand the prevalence and control of the infections. Regional and local infections should be investigated and properly addressed through random sampling. For implementing control and eradication studies at a national level, full genome sequence data should be provided in further studies.
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